Cargando…
Serum procalcitonin is a marker for prediction of readmission from an intermediate care to an acute care hospital in neurosurgical patients
BACKGROUND: Readmission of patients to acute hospitals contributes significantly toward inefficient utilization of healthcare resources, with studies quoting up to 90% being preventable. We aim to report and analyze the factors involved in the readmission of neurosurgical patients who had been previ...
Autores principales: | Lim, Jia Xu, King, Nicolas, Low, Sharon, Ng, Wai Hoe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561388/ https://www.ncbi.nlm.nih.gov/pubmed/26430533 http://dx.doi.org/10.4103/2152-7806.163819 |
Ejemplares similares
-
Causes of hospital readmissions within 7 days from the neurosurgical service of a quaternary referral hospital
por: Nwachuku, Enyinna L., et al.
Publicado: (2020) -
Serum procalcitonin as a diagnostic marker of neonatal sepsis
por: Park, In Ho, et al.
Publicado: (2014) -
Using hospital readmission rates to track the quality of care in public hospitals in Singapore
por: Lim, E, et al.
Publicado: (2011) -
Bedside procalcitonin and acute care
por: Singh, Manpreet, et al.
Publicado: (2014) -
Structure of Neurosurgical Care in Germany in Comparison to Countries Organized in the European Association of Neurosurgical Societies: A Need to Reorganize Neurosurgical Training and Care in Germany
por: Ringel, Florian, et al.
Publicado: (2023)